Idorsia (IDRSF) News Today $0.91 0.00 (0.00%) As of 01/17/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Idorsia Ltd (OTCMKTS:IDRSF) Sees Significant Decrease in Short InterestJanuary 19 at 3:15 AM | americanbankingnews.comIdorsia Pharmaceuticals Ltd: Idorsia presents at J.P. Morgan Healthcare Conference 2025 - fighting to create value for all stakeholdersJanuary 16, 2025 | finanznachrichten.deSanthera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by IdorsiaJanuary 16, 2025 | markets.businessinsider.comIdorsia presents at J.P. Morgan Healthcare Conference 2025 – fighting to create value for all stakeholdersJanuary 15, 2025 | globenewswire.comKepler Capital Keeps Their Hold Rating on Idorsia Ltd (IDIA)January 15, 2025 | markets.businessinsider.comIdorsia publishes an invitation to a bondholder meetingJanuary 14, 2025 | globenewswire.comIdorsia Pharmaceuticals Ltd: Idorsia to call for a bondholder meetingJanuary 13, 2025 | finanznachrichten.deIdorsia Shares Plunge After Proposing Changes to Bonds TermsJanuary 13, 2025 | marketwatch.comIdorsia to call for a bondholder meetingJanuary 13, 2025 | globenewswire.comIdorsia Pharmaceuticals Ltd: Idorsia provides update on the exclusive negotiations for the global rights to aprocitentanDecember 20, 2024 | finanznachrichten.deIdorsia Shares Plunge After Hypertension Drug Deal StallsDecember 20, 2024 | marketwatch.comIdorsia provides update on the exclusive negotiations for the global rights to aprocitentanDecember 20, 2024 | globenewswire.comIdorsia, with U.S. operations on the Main Line, expects to cut hundreds of jobsNovember 29, 2024 | bizjournals.comSwiss pharma firm Idorsia plans debt restructuring, job cutsNovember 27, 2024 | reuters.comIdorsia enters into exclusive negotiations for global rights to aprocitentanNovember 27, 2024 | globenewswire.comIdorsia's once-daily TRYVIO™ (aprocitentan) is now available in the U.S., advancing treatment options for millions of patients with difficult-to-control hypertensionNovember 15, 2024 | prnewswire.comIdorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association (AHA) Scientific SessionsNovember 11, 2024 | globenewswire.comOne Idorsia Ltd (VTX:IDIA) Analyst Just Slashed Their Estimates By A Considerable 33%November 6, 2024 | finance.yahoo.comIdorsia upgraded to Hold from Sell at Deutsche BankNovember 5, 2024 | markets.businessinsider.comIdorsia rating suspended at Goldman SachsOctober 30, 2024 | markets.businessinsider.comIdorsia price target lowered to CHF 1.20 from CHF 2 at JPMorganOctober 22, 2024 | markets.businessinsider.comSome Analysts Just Cut Their Idorsia Ltd (VTX:IDIA) EstimatesOctober 20, 2024 | finance.yahoo.comIdorsia continues to further the science of sleep and insomnia with new daridorexant data and analyses published at Sleep Europe 2024September 17, 2024 | globenewswire.comAmended terms of Idorsia’s 2024 convertible bonds become effectiveSeptember 2, 2024 | uk.finance.yahoo.comIdorsia Pharmaceuticals Ltd: Amended terms of Idorsia's 2024 convertible bonds become effectiveSeptember 2, 2024 | finanznachrichten.deAmended terms of Idorsia's 2024 convertible bonds become effectiveSeptember 2, 2024 | globenewswire.comMaintaining Hold on Idorsia: Awaiting Clarity on Tryvio Partnerships and Commercialization StrategyJuly 30, 2024 | markets.businessinsider.comIdorsia Ltd (IDRSF) Q2 2024 Earnings Call TranscriptJuly 27, 2024 | seekingalpha.comIdorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first half 2024July 25, 2024 | finanznachrichten.deIdorsia Ltd (VTX:IDIA) most popular amongst individual investors who own 38%, insiders hold 32%July 25, 2024 | finance.yahoo.comIdorsia Pharmaceuticals Ltd: Invitation to Idorsia's Half Year 2024 Financial Reporting webcast and conference callJuly 20, 2024 | finanznachrichten.deInvitation to Idorsia's Half Year 2024 Financial Reporting webcast and conference callJuly 18, 2024 | globenewswire.comIdorsia's JERAYGO (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertensionJuly 1, 2024 | globenewswire.comIdorsia's novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the ‘Primary & Speciality' categoryJune 21, 2024 | globenewswire.comIdorsia holds its Annual General Meeting of ShareholdersJune 13, 2024 | globenewswire.comIdorsia Ltd (IDRSF)May 24, 2024 | finance.yahoo.comIdorsia issues invitation to the 2024 Annual General Meeting of ShareholdersMay 23, 2024 | globenewswire.comIdorsia announces changes to Idorsia Executive Committee and Board of DirectorsMay 21, 2024 | globenewswire.comIdorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable valueMay 21, 2024 | globenewswire.comInvitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and conference callMay 14, 2024 | globenewswire.comIdorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bondMay 1, 2024 | globenewswire.comIdorsia Ltd (VTX:IDIA) Analysts Just Cut Their EPS Forecasts SubstantiallyApril 27, 2024 | finance.yahoo.comJERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertensionApril 26, 2024 | finance.yahoo.comIdorsia publishes an invitation to a bondholder meetingApril 23, 2024 | globenewswire.comIdorsia publishes a Financial Status required for an upcoming bondholder meetingApril 17, 2024 | finance.yahoo.comIdorsia takes steps to address short-term liquidity needsApril 11, 2024 | globenewswire.comIdorsia gets FDA approval for high blood pressure drug TryvioMarch 22, 2024 | bizjournals.comIdorsia: Aprocitentan Approval Is A Vital NewsMarch 22, 2024 | seekingalpha.comIdorsia thanks Guy Braunstein for his years of service as he retiresMarch 22, 2024 | globenewswire.comFDA approves Idorsia’s once-daily antihypertensive TryvioMarch 20, 2024 | msn.com Get Idorsia News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRSF and its competitors with MarketBeat's FREE daily newsletter. Email Address IDRSF Media Mentions By Week IDRSF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDRSF News Sentiment▼0.360.44▲Average Medical News Sentiment IDRSF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDRSF Articles This Week▼51▲IDRSF Articles Average Week Get Idorsia News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRSF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News Today AKBLF News Today DRTSW News Today APLMW News Today ARNI News Today ASPHF News Today ASCLF News Today AVCTF News Today AWKNF News Today AXIM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IDRSF) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Idorsia Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Idorsia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDRSF Stock Alerts